REOLYSIN®
REO 023
Phase 1 mab terminated
Quick answer
REOLYSIN® for Muscle-invasive Transitional Cell Carcinoma of the Bladder is a Phase 1 program (mab) at ONCOLYTICS BIOTECH INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ONCOLYTICS BIOTECH INC
- Indication
- Muscle-invasive Transitional Cell Carcinoma of the Bladder
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated